Precursor Cell Lymphoblastic Leukemia-LymphomaIntensive Care UnitsMortalityIntensive CareLeukemia, Myeloid, AcuteAsparaginaseLiver Failure, AcuteHospital MortalityIntensive Care Units, NeonatalPrognosisMyeloid-Lymphoid Leukemia ProteinTreatment OutcomeIntensive Care Units, PediatricInfant, NewbornAcute DiseaseRetrospective StudiesInfant MortalityCohort StudiesSurvival AnalysisGene Expression Regulation, LeukemicPrecursor B-Cell Lymphoblastic Leukemia-LymphomaCore Binding Factor Alpha 2 SubunitRecurrenceProspective StudiesOncogene Proteins, FusionCause of DeathSurvival RateHospitals, PediatricRisk FactorsRisk AssessmentDaunorubicinRemission InductionIntensive Care, NeonatalPediatricsAge FactorsLeukemia, MyeloidAcute Lung InjuryDisease-Free SurvivalTranslocation, GeneticIdarubicinNeoplasm, Residualfms-Like Tyrosine Kinase 3Time FactorsChromosomes, Human, Pair 21Child MortalityCritical IllnessMaternal MortalityKaplan-Meier EstimateFollow-Up StudiesPredictive Value of TestsGene Expression ProfilingBone MarrowAntineoplastic Combined Chemotherapy ProtocolsCytarabineLength of StayMethotrexateCritical CareProportional Hazards ModelsKaryotypingLeukemiaReverse Transcriptase Polymerase Chain ReactionUnited StatesChromosome AberrationsOligonucleotide Array Sequence AnalysisIncidenceAntineoplastic AgentsDrug Resistance, NeoplasmAPACHERespiration, ArtificialCardiovascular DiseasesHospital UnitsCross InfectionSepsisPolymerase Chain ReactionSeverity of Illness IndexMortality, PrematureMutationPerinatal MortalityMultivariate AnalysisPostoperative ComplicationsAge DistributionSex FactorsCoronary Care UnitsLogistic ModelsMorbidityPatient AdmissionRegistriesFlow CytometryProto-Oncogene ProteinsSex DistributionGene Expression Regulation, NeoplasticNeoplasmsDeath CertificatesApoptosisFetal MortalityCell Line, TumorRiskRegression AnalysisMyocardial InfarctionLife Expectancy